SK Biopharmaceuticals JV 'Mentis Care' Launches AI-Based Seizure Detection and Prediction Research with Emory University School of Medicine
Two-Year Joint Research with Emory University School of Medicine
Utilizing Over 1 Million Hours of EEG Data
Laying the Groundwork for Real-Time Epilepsy Monitoring
SK Biopharmaceuticals announced on March 17 that its joint venture, Mentis Care, has initiated a two-year collaborative research project with Emory University School of Medicine in the United States to develop a universal AI model for seizure detection and prediction.
This joint research aims to develop a transformer-based EEG foundation model that operates consistently across various environments, ranging from the standard 10-20 EEG system used in clinical settings to reduced-channel wearable EEG devices. The goal is to establish the technological foundation necessary for continuous epilepsy monitoring in real-world settings.
Through this collaboration, Mentis Care will conduct research utilizing over 1 million hours of de-identified EEG data held by Emory University School of Medicine. The joint research will focus on five key pillars: large-scale data curation and the establishment of a standardized preprocessing pipeline; development of a high-performance foundation model for seizure detection; validation across diverse patient groups and recording environments; model adaptation for reduced-channel wearable EEG systems; and expansion of real-time pre-seizure prediction modules. However, as this research is still in its early stages, additional development, clinical trials, and reviews and approvals from relevant regulatory authorities are required before commercialization can be achieved.
Hassan Koutop, CEO of Mentis Care, stated, "The universal AI model we aim to develop through this joint research with Emory University School of Medicine will serve as a core foundational technology that enables continuous, real-life monitoring. For one in three patients whose seizures are uncontrolled, this could represent a fundamental change in the future."
Samaneh Nasiri, PhD at Emory University School of Medicine, said, "Foundation models are opening up new possibilities across healthcare. This collaboration will broaden the potential applications of EEG and serve as an important foundation for expanding our understanding of brain function." Garry Clifford, Chair of Biomedical Informatics at Emory University, added, "This joint research will accelerate large-scale EEG analysis and serve as an opportunity to benefit a wide range of disease areas."
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Through this collaboration with Mentis Care and Emory University, SK Biopharmaceuticals aims to further advance its proprietary AI-powered EEG analysis technology and wearable device capabilities. The company views this collaboration as an opportunity to expand the technological base of the digital healthcare sector. Lee Donghun, CEO of SK Biopharmaceuticals, stated, "Beyond innovative new drugs, SK Biopharmaceuticals is exploring new possibilities in patient care through AI-based digital healthcare. Through Mentis Care, we will continue to drive patient-centered treatment innovation by integrating AI technology."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.